GleamWall
中文EN

PYPD PolyPid Ltd.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1611842 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-17.7%
TTM EPS YoY-57.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-366.3%
ROA-143.8%
ROIC (approx.)-1,290.9%
Asset turnover—

Leverage & solvency

Liabilities / assets50.8%
Debt / equity0.00x
Current ratio1.97x
Interest coverage-37.72x

Cash quality & payout

Operating cash flow / net income0.82x
Accruals ratio-26.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2025Q22025-06-302024Q22024-06-302023Q22023-06-302022Q22022-06-302021Q22021-06-302020Q22020-06-30
Income statement
Revenue——————
R&D expense$6.21M$4.76M$3.96M$8.40M$7.44M$4.34M
SG&A expense$2.49M$1.10M$1.50M$2.24M$2.45M$2.63M
Operating income-$9.40M-$6.12M-$5.82M-$11.56M-$10.63M-$7.27M
Pretax income-$9.92M-$6.29M-$5.83M———
Income tax$53,000$2,000$10,000———
Net income-$9.98M-$6.29M-$5.84M-$11.85M-$10.48M-$16.99M
EPS (basic)0.781.253.950.610.5625.30
EPS (diluted)0.781.253.950.610.5625.30
Weighted avg. shares (diluted)12.84M5.02M1.48M19.51M18.75M755,289
Balance sheet
Cash & equivalents$17.45M$3.08M$3.40M$11.64M$8.03M—
Current assets$29.99M$9.78M$15.75M$25.02M$49.17M—
PP&E, net$5.34M$6.81M$8.53M$9.18M$5.73M—
Total assets$37.69M$19.53M$26.26M$34.82M$61.40M—
Current liabilities$13.15M$10.29M$5.45M$8.70M$4.32M—
Short-term debt$6.55M$5.44M$2.07M$2.17M——
Long-term debt—$3.13M$8.54M———
Total debt—$8.56M$10.61M———
Total liabilities$17.21M$17.93M$17.92M$15.71M$4.51M—
Shareholders' equity$20.48M$1.60M$8.35M$19.11M$56.88M$84.48M
Net debt—$5.49M$7.21M———
Shares outstanding15.65M4.80M49.05M19.55M18.76M—
Cash flow statement
Operating cash flow——————

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.